Pricing Log in Create free account
Friday 6 November 2026 Export AMN’s income statement to Excel — free account

AMN Healthcare Services Inc

AMN Healthcare Medical Care Facilities

AMN Healthcare Services Inc’s revenue for fiscal 2025 (year ended December 2025) was $2.7 billion, down 8.49% from fiscal 2024.

Revenue
+13.1%
EPS
+11.8%
Free cash flow
−389.4%
Total debt
−18.9%

Quarter to September 2026, against a year earlier

47.01 0.73 −1.53%
Market cap
$1.8B
P/E
16.8×
Fwd P/E
25.4×
Dividend yield
—
F-score
5/9
Altman Z
2.26
Beneish M
−3.39
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Insider Decisions last twelve months

Sold, $m 0.11
Trades a month
Jan 26 Apr 26 Jul 26 Oct 26
Buy — — — — — — — — — — — —
Sell — — — — — — 1 — — — — —
Insider Ownership 1.97%

Capital & Financial Ratios $m

Size
Market Cap 1,840.00
Revenue ttm 3,517.10
Net income ttm 109.02
Free cash flow ttm 327.03
Net debt Q (255.98)
Valuation
P/E 16.85
Forward P/E 25.40
Price / sales 0.52
Forward P/S Powerpack
Price / FCF 5.66
Price / book 2.37
Financial health
Current ratio Q 1.21
Debt / equity Q 0.00 (at or below 0.5: strong)
Interest coverage Q 6.89
Growth
Revenue growth Q +13.05% (above 0%: growing)
Operating income growth Q +6.09% (above 0%: growing)
EPS, this year +141.80% (at or above 15%: strong)
EPS, next year A −71.45% (below 0%: weak)
Revenue, next year A +22.87% (at or above 10%: strong)
EPS, past 5 yrs —
EPS, next 5 yrs A −2.45% (below 0%: weak)

Green and red mark values outside typical ranges; (Q) is the latest quarter, (A) analysts’ estimates. How we judge →

Valuation vs history

EV/Sales, ten years
EV/Sales is 0.7×, against a ten-year median of 1.2×; over the ten years it ranged from 0.3× in 2026 to 2.1× in 2021.
P/E against its own 10 years 42.57%
10-year low 10-year high
P/S against its own 10 years 19.36%
10-year low 10-year high
P/B against its own 10 years 21.05%
10-year low 10-year high
EV/Sales against its own 10 years 15.47%
10-year low 10-year high
EV/FCF against its own 10 years 14.15%
10-year low 10-year high

Dividends

Yield
—
Annual rate
—
Payout ratio
—

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 33 11 34 256
Receivables 741 508 431 —
Inventory — — — —
Other 46 53 60 63
842 595 545 804
2023 2024 2025 Q'26
Payables 344 184 162 190
ST’ Debt — — — —
Other 34 74 117 130
656 546 578 666

Compound Annual Growth %

10y 5y 3y
Sales 6.44% 2.67% (19.55%)
Cash Flow 16.95% 0.96% (25.58%)
Earnings 0.00% 0.00% 0.00%
Book Value 6.32% (4.77%) (14.95%)

Earnings Trends EPS, adjusted, against the consensus

Q2 FY26 Estimate 0.22 Actual 0.77

Earnings per share against the consensus, by quarter
Quarter Estimate Reported Result
Q3 FY25 0.19 0.39 Beat by 0.20
Q4 FY25 0.22 0.22 Met by 0.00
Q1 FY26 1.60 2.10 Beat by 0.50
Q2 FY26 0.22 0.77 Beat by 0.55
Q3 FY26 0.22 — Reports 5 November 2026

EPS $

Mar Jun Sep Dec Year
’26 1.59 0.53 0.83 — —
’25 (0.03) (3.02) 0.76 (0.20) (2.48)
’24 0.45 0.42 0.18 (4.90) (3.85)
’23 2.02 1.55 1.39 0.33 5.36
’22 3.09 2.77 2.10 1.88 9.90
’21 1.47 1.39 1.54 2.42 6.81
’20 0.27 0.47 0.55 0.19 1.48
Fiscal quarters ending in the months shown.

Revenue $m

Mar Jun Sep Dec Year
’26 1,378 673 717 — —
’25 690 658 634 748 2,730
’24 821 741 688 735 2,984
’23 1,126 991 853 818 3,789
’22 1,553 1,427 1,139 1,126 5,243
’21 886 857 878 1,363 3,984
’20 602 608 552 631 2,394
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 562 (190) (88) — —
’25 93 79 23 76 269
’24 81 100 67 73 320
’23 43 198 172 (41) 372
’22 200 224 114 115 654
’21 39 171 17 78 305
’20 51 77 89 40 257
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 555 (199) (97) — —
’25 83 69 15 68 234
’24 63 72 47 57 240
’23 26 171 142 (73) 267
’22 187 206 89 91 573
’21 28 160 1 63 252
’20 36 71 81 30 218
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

2.4
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Ten-year view Analyst estimates Powerpack
Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 TTM Sep ’26 Trend 10 yrs 2026e 2027e 2028e Next 3/yr
Income, $m
Income, $m Revenue 1,902 1,988 2,136 2,222 2,394 3,984 5,243 3,789 2,984 2,730 3,517 +4.1% 3,355 2,670 2,781 +0.6%
Gross margin, % 32.58 32.41 32.60 33.46 33.08 32.87 32.74 32.98 30.81 28.35 28.40 (4.2) pt
EBT 176 193 187 148 92 444 607 284 (173) (101) 169 n/m
EBT margin, % 9.26 9.69 8.74 6.68 3.82 11.14 11.57 7.50 (5.78) (3.70) 4.82 (13.0) pt
Net income 106 133 142 114 71 327 444 211 (147) (96) 109 n/m
Per share, $
Per share, $ Revenue 39.67 41.59 45.09 47.58 50.47 83.55 117.59 96.73 78.13 70.88 89.93 +6.7%
Earnings 2.21 2.77 2.99 2.44 1.49 6.87 9.96 5.38 (3.85) (2.48) 2.79 n/m
Cash flow 2.79 3.36 4.79 4.81 5.42 6.40 14.66 9.50 8.39 7.00 9.22 +10.7%
Capex (0.46) (0.55) (0.77) (0.78) (0.82) (1.13) (1.81) (2.69) (2.12) (0.92) (0.86) +8.1%
Free cash flow 2.34 2.80 4.02 4.03 4.59 5.28 12.85 6.81 6.27 6.07 8.36 +11.2%
Book value 9.37 11.77 13.49 15.77 17.28 24.37 23.40 21.22 18.50 16.67 19.82 +6.6%
Shares, m 48 48 47 47 47 48 45 39 38 39 39 (2.4%)
Valuation, ×
Valuation, × P/E 17.74 17.91 18.95 25.54 45.81 17.83 10.72 14.58 0.00 0.00 16.85 16.9
P/S 0.99 1.19 1.26 1.31 1.35 1.46 0.90 0.80 0.31 0.22 0.52 1.0
P/B 4.18 4.22 4.20 3.95 3.95 5.02 4.53 3.65 1.29 0.95 2.37 3.6
EV/Sales 1.17 1.35 1.46 1.55 1.70 1.63 1.05 1.14 0.66 0.49 0.66 1.2
EV/FCF 19.90 19.97 16.22 18.28 18.67 25.80 9.61 16.39 8.38 5.77 7.16 15.9
Cash, $m
Cash, $m Operating cash flow 134 161 227 225 257 305 654 372 320 269 361 +8.1%
Capex (22) (27) (36) (36) (39) (54) (81) (105) (81) (36) (34) +5.5%
Free cash flow 112 134 191 188 218 252 573 267 240 234 327 +8.5%
Balance, $m
Balance, $m Working capital 176 209 175 182 111 380 236 186 49 (32) 138 n/m
Net debt 349 305 427 534 829 661 779 1,272 1,045 733 (256) +8.6%
Shareholders’ equity 449 563 639 737 820 1,162 1,044 831 707 642 775 +4.0%
Returns, %
Returns, % ROA 10.24 10.86 10.32 6.66 3.30 11.94 14.75 7.25 (5.50) (4.24) 4.92 (14.5) pt
ROIC 15.01 15.31 11.89 8.70 5.66 16.38 22.19 10.06 (3.66) (2.52) 24.41 (17.5) pt
ROE 26.55 26.20 23.59 16.57 9.08 33.04 40.26 22.47 (19.11) (14.19) 15.36 (40.7) pt
People
People Employees 2,990 2,980 2,920 3,236 3,000 3,800 4,230 3,585 2,968 2,664 — (1.3%)
Revenue/emp, $m 0.64 0.67 0.73 0.69 0.80 1.05 1.24 1.06 1.01 1.02 — +5.4%
Negative figures in brackets.
estimates

All 10 years →

Fiscal years to Dec 2025 · latest quarter Sep 2026 · fundamentals updated 6 Nov 2026

AMN Healthcare Services Inc vs peers in Medical Care Facilities (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
ADUS Addus HomeCare Corporation $2.4B 21.1× 20.3× +7.02% (above 0%: growing) +24.19% (above 0%: growing) −17.07% (below 0%: shrinking) 32.08% 10.27% Compare
ARDT Ardent Health, Inc. $2.2B 15.2× 12.8× +3.05% (above 0%: growing) n/m −23.49% (below 0%: shrinking) 100.00% 0.00% Compare
ASTH Astrana Health, Inc. $1.9B 46.8× 25.9× +48.52% (above 0%: growing) +110.53% (above 0%: growing) −67.74% (below 0%: shrinking) 10.70% 3.53% Compare
AGL Agilon Health, Inc. $1.9B — (loss-making) — (loss-making) +5.86% (above 0%: growing) n/m +234.38% (above 0%: growing) 0.00% 1.59% Compare
AMN AMN Healthcare Services Inc $1.8B 17.4× 25.4× +2.29% (above 0%: growing) +117.88% (above 0%: growing) −389.43% (below 0%: shrinking) 30.58% 4.00%
HCSG Healthcare Services Group, Inc. $1.7B 16.6× 18.6× +3.29% (above 0%: growing) −37.29% (below 0%: shrinking) −59.81% (below 0%: shrinking) 16.76% 6.66% Compare
SNDA Sonida Senior Living, Inc. $1.6B — (loss-making) — (loss-making) +114.40% (above 0%: growing) n/m +360.11% (above 0%: growing) 35.68% (9.27%) Compare
PNTG The Pennant Group, Inc. $1.4B 37.3× 36.7× +31.96% (above 0%: growing) +55.56% (above 0%: growing) −3.19% (below 0%: shrinking) 13.34% 5.46% Compare
NUTX Nutex Health Inc. $1.3B 7.4× 7.3× −13.62% (below 0%: shrinking) n/m +19.44% (above 0%: growing) 67.04% 57.75% Compare
Median of peers $1.8B 18.9× 19.5× +6.44% +39.88% −10.13% 24.42% 4.50%

All 51 Medical Care Facilities stocks →

Pay and ownership Proxy statement filed 18 March 2026

Ownership

Directors and executive officers, together less than 1%
BlackRock, Inc. 15.10%
The Vanguard Group 9.40%
Millennium Management LLC 5.20%
Ownership is the proxy’s own table: the directors and officers as a group, and every holder of 5% or more. Read the proxy statement

AMN Healthcare Services Inc (AMN) Latest News

6 Nov

Impact 3 · · GuruFocus.com

5 Nov

Impact 3 · · Zacks
Impact 3 · · Zacks
Impact 3 · · StockStory
Impact 3 · · Associated Press
Impact 3 · · PR Newswire

27 Oct

Impact 4 · · Zacks
Impact 3 · · Zacks

24 Oct

Impact 3 · · Simply Wall St.

23 Oct

Impact 3 · · Zacks

22 Oct

Impact 3 · · StockStory

17 Oct

Impact 4 · · Simply Wall St.

12 Oct

Impact 3 · · Zacks

9 Oct

Impact 3 · · Simply Wall St.

7 Oct

Impact 3 · · PR Newswire
Impact 3 · · StockStory

6 Oct

Impact 3 · · PR Newswire
Impact 3 · · StockStory

15 Sep

Impact 3 ·
Impact 3 ·

24 Aug

Impact 4 ·

14 Aug

Impact 4 · · The Motley Fool transcript
Impact 3 ·

12 Aug

Impact 4 ·

11 Aug

Impact 4 ·

9 Aug

Impact 3 ·
Impact 3 ·

7 Aug

Impact 4 ·
Impact 3 · · MarketBeat transcript
Impact 3 ·
stockrow.com/AMN · Data as of Nov 6, 2026 · For information only; not investment advice. · © 2026 stockrow.com